Enlarging the scope of cell-penetrating prenylated peptides to include farnesylated 'CAAX' box sequences and diverse cell types

Chemical Biology and Drug Design

Volumn 76, Issue 2, 2010, Pages 107-115

  Ochocki, Joshua D ^a   Igbavboa, Urule ^b   Gibson Wood, W ^b   Wattenberg, Elizabeth V ^c   Distefano, Mark D ^a  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

amino acid; carbohydrate; chemical biology; lipid; nucleic acid; peptide

Indexed keywords

6 CARBOXYFLUORESCEIN; CELL PENETRATING PEPTIDE; DISULFIDE; NUCLEIC ACID; PROTEIN FARNESYLTRANSFERASE; RAS PROTEIN; FARNESYL TRANS TRANSFERASE; FLUORESCENT DYE; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TYPE; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; FLOW CYTOMETRY; HELA CELL; IN VITRO STUDY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PRENYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; HUMAN; METABOLISM; MOUSE; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; FARNESYLTRANSTRANSFERASE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; MICE; MICROSCOPY, CONFOCAL; PEPTIDES; PROTEIN PRENYLATION;

EID: 77954363076     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.00992.x     Document Type: Article

References (40)

1. Ohkanda J., Knowles D.B., Blaskovich M.A., Sebti S.M., Hamilton A.D. (2002) Inhibitors of protein farnesyltransferase as novel anticancer agents. Curr Top Med Chem 2 : 303 323.
2. Eckert G.P., Hooff G.P., Strandjord D.M., Igbavboa U., Volmer D.A., Muller W.E., Wood G.W. (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35 : 251 257.
3. Hooff G.P., Volmer D.A., Wood W.G., Mueller W.E., Eckert G.P. (2008) Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP). Anal Bioanal Chem 392 : 673 680.
4. Epstein W.W., Lever D., Leining L.M., Bruenger E., Rilling H.C. (1991) Quantitation of prenylcysteines by a selective cleavage reaction. Proc Natl Acad Sci U S A 88 : 9668 9670.
5. Seabra M.C. (1998) Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal 10 : 167 172.
6. Benetka W., Koranda M., Eisenhaber F. (2006) Protein prenylation: an (almost) comprehensive overview on discovery history, enzymology, and significance in physiology and disease. Monatsh Chem 137 : 1241 1281.
7. Casey P.J. (1992) Biochemistry of protein prenylation. J Lipid Res 33 : 1731 1740.
8. Clarke S. (1992) Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem 61 : 355 386.
9. Zhang F.L., Casey P.J. (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65 : 241 269.
10. Winter-Vann A.M., Casey P.J. (2005) Post-prenylation-processing enzymes as new targets in oncogenesis. Nat Rev Cancer 5 : 405 412.
11. Blum R., Kloog Y. (2005) Tailoring Ras-pathway-Inhibitor combinations for cancer therapy. Drug Resist Updat 8 : 369 380.
12. Karp J.E., Lancet J.E. (2007) Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies. Cancer Invest 25 : 484 494.
13. Zhu K., Hamilton A.D., Sebti S.M. (2003) Farnesyltransferase inhibitors as anticancer agents: current status. Curr Opin Investig Drugs 4 : 1428 1435.
14. Adjei A.A., Mauer A., Bruzek L., Marks R.S., Hillman S., Geyer S. et al. (2003) Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer. J Clin Oncol 21 : 1760 1766. (Pubitemid 46638589)
15. Cortes J., Albitar M., Thomas D., Giles F., Kurzrock R., Thibault A. et al. (2003) Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. Blood 101 : 1692 1697.
16. Mukherjee J., Guha A. Handbook of Brain Tumor Chemotherapy. Newton H.B., editor : Elsevier 2006.
17. Sousa S.F., Fernandes P.A., Ramos M.J. (2008) Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. Curr Med Chem 15 : 1478 1492.
18. Lindorfer M.A., Sherman N.E., Woodfork K.A., Fletcher J.E., Hunt D.F., Garrison J.C. (1996) G protein gamma subunits with altered prenylation sequences are properly modified when expressed in Sf9 cells. J Biol Chem 271 : 18582 18587.
19. Fenton J.W. II., Jeske W.P., Catalfamo J.L., Brezniak D.V., Moon D.G., Shen G.X. (2002) Statin drugs and dietary isoprenoids downregulate protein prenylation in signal transduction and are antithrombotic and prothrombolytic agents. Biochemistry (Mosc) 67 : 85 91.
20. Workman P. Farnesyltransferase Inhibitors in Cancer Therapy. Sebti S.M., Hamilton A.D., editors : Humana Press Inc. 2001.
21. Roy M.-O., Leventis R., Silvius J.R. (2000) Mutational and biochemical analysis of plasma membrane targeting mediated by the farnesylated, polybasic carboxy terminus of K-ras4B. Biochemistry 39 : 8298 8307.
22. Waldmann H., Schelhaas M., Nagele E., Kuhlmann J., Wittinghofer A., Schroeder H. et al. (1997) Chemoenzymic synthesis of fluorescent N-Ras lipopeptides and their use in membrane localization studies in vivo. Angew Chem Int Ed Engl 36 : 2238 2241.
23. Wollack J.W., Zeliadt N.A., Mullen D.G., Amundson G., Geier S., Falkum S. et al. (2009) Multifunctional prenylated peptides for live cell analysis. J Am Chem Soc 131 : 7293 7303.
24. Greene L.A., Tischler A.S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73 : 2424 2428.
25. King D.S., Fields C.G., Fields G.B. (1990) A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int J Pept Protein Res 36 : 255 266.
26. Meriin A.B., Yaglom J.A., Gabai V.L., Zon L., Ganiatsas S., Mosser D.D. et al. (1999) Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: a novel pathway controlled by HSP72. Mol Cell Biol 19 : 2547 2555.
27. Mazia D., Schatten G., Sale W. (1975) Adhesion of cells to surfaces coated with polylysine. Applications to electron microscopy. J Cell Biol 66 : 198 200.
28. Yousif L.F., Stewart K.M., Horton K.L., Kelley S.O. (2009) Mitochondria-penetrating peptides: sequence effects and model cargo transport. Chembiochem 10 : 2081 2088.
29. Xue C.B., Becker J.M., Naider F. (1992) Efficient regioselective isoprenylation of peptides in acidic aqueous solution using zinc acetate as catalyst. Tetrahedron Lett 33 : 1435 1438.
30. Moores S.L., Schaber M.D., Mosser S.D., Rands E., O'Hara M.B., Garsky V.M. et al. (1991) Sequence dependence of protein isoprenylation. J Biol Chem 266 : 14603 14610.
31. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J. et al. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278 : 585 590.
32. Wollack J.W., Zeliadt N.A., Ochocki J.D., Mullen D.G., Barany G., Wattenberg E.V. et al. (2010) Investigation of the sequence and length dependence for cell-penetrating prenylated peptides. Bioorg Med Chem Lett 20 : 161 163.
33. Levine R.L., Moskovitz J., Stadtman E.R. (2000) Oxidation of methionine in proteins: roles in antioxidant defense and cellular regulation. IUBMB Life 50 : 301 307.
34. Du W., Cui Z., Tsui Z.C., Chen Q., Willingham M.C. (2008) In situ immunocytochemical detection of altered membrane composition induced by cell-cell contact in cultured mammalian cells. Microsc Res Tech 71 : 749 759.
35. Massodi I., Bidwell G.L. III., Raucher D. (2005) Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery. J Control Release 108 : 396 408.
36. Stewart E.J., Aslund F., Beckwith J. (1998) Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins. EMBO J 17 : 5543 5550.
37. Wright L.P., Philips M.R. (2006) Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res 47 : 883 891.
38. Arkhipov S.N., Berezovski M., Jitkova J., Krylov S.N. (2005) Chemical cytometry for monitoring metabolism of a Ras-mimicking substrate in single cells. Cytometry A 63A : 41 47.
39. Berezovski M., Li W.-P., Poulter C.D., Krylov S.N. (2002) Measuring the activity of farnesyltransferase by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 23 : 3398 3403.
40. Jitkova J., Carrigan C.N., Poulter C.D., Krylov S.N. (2004) Monitoring the three enzymatic activities involved in posttranslational modifications of Ras proteins. Anal Chim Acta 521 : 1 7.